Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Antibodies (Basel, Switzerland)|November 22, 2022
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-BoosterChin Shern Lau, John Thundyil, May Lin Helen Oh, et al.
BMJ Open Quality|April 4, 2018
Reducing the number of invalid surgical consents in the day surgery unitWesley Chong, Allan Chee Yang Fong, Yi Lin Yeo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2023
Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptomsOoiean Teng, Amy May Lin Quek, Tuong Minh Nguyen, et al.
Scientific Reports|June 21, 2026
Profiling of immunomodulatory anti-cytokine autoantibodies associated with disease heterogeneity in a multiethnic Asian cohortBhuvaneshwari Shunmuganathan, Rashi Gupta, Ooiean Teng, et al.
Bioconjugate Chemistry|July 24, 2020
Nanolipoprotein Particles as a Delivery Platform for Fab Based TherapeuticsMartine Darwish, Whitney Shatz, Brandon Leonard, et al.
Redox Biology|August 17, 2019
α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injuryMaria Wallert, Melanie Ziegler, Xiaowei Wang, et al.
Human Vaccines & Immunotherapeutics|February 24, 2021
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trialJuliana Park, Sophia Archuleta, May-Lin Helen Oh, et al.
Nature Communications|September 30, 2025
Disulfide-constrained Fabs overcome target size limitation for high-resolution single particle cryoEMJennifer E Kung, Matthew C Johnson, Dimitry Tegunov, et al.
Human Vaccines & Immunotherapeutics|August 17, 2012
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in SingaporeYee Sin Leo, Anneliese Wilder-Smith, Sophia Archuleta, et al.
Scientific Reports|March 15, 2018
Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injuryEhsan Sharif-Paghaleh, May Lin Yap, Sarah-Lena Puhl, et al.
Pageof 13